A new combination therapy that pairs a radiopharmaceutical (¹⁷⁷Lu-DOTATATE) with a DNA-repair blocker (olaparib) has been deemed feasible and tolerable for neuroendocrine cancer patients. The combined therapy works by preventing cancer cells from repairing themselves after targeted treatment and has the potential to help patients achieve longer-lasting disease control. This research was published in the May issue of The Journal of Nuclear Medicine.

The treatment of leukaemia among children could be made more precise with fewer side effects with the help of more accurate methods of diagnosis. A new study led by Umeå University, Sweden, reveals that analyzing methylation patterns in the child's leukemic cells DNA can enhance risk assessment, helping to ensure that only the children who need the most intensive treatment receive it.

The bacteria that cause tuberculosis (TB) may have an “on-off switch” that lets them pause and restart growth, according to a new study from the University of Surrey and the University of Oxford. The research helps explain why TB is so hard to treat with antibiotics and could pave the way for better drugs. 

The Philippines faces a chronic shortage of nurses and physicians, and many health graduates are unprepared for real-world public health work.

The Academy of Medical and Health Sciences of Catalonia and the Balearic Islands held its 2025 Scholarships and Awards ceremony this week. Dr Manel Esteller, from the Josep Carreras Leukaemia Research Institute, and Dr Salvador Macip were honoured with the Jaume Aiguader i Miró Award for their book “The Secret of Eternal Life”, which explores the biological mechanisms associated with ageing and longevity, and how this topic is addressed from both medical and societal perspectives.

POSTECH and Hanyang University Joint Research Team Develops Advanced Technology to Treat Urinary Disorders through Tibial Nerve Stimulation.